NYSE:GMED

Globus Medical - GMED Stock Forecast, Price & News

$63.79

+0.27 (+0.43%)

(As of 08/9/2022 12:00 AM ET)

Add

Compare

Today's Range: $63.25
▼
$64.03
50-Day Range: $53.08
▼
$66.59
52-Week Range: $52.60
▼
$84.23

Volume: 741,489 shs
Average Volume: 708,700 shs
Market Capitalization: $6.49 billion

P/E Ratio: 42.81
Dividend Yield: N/A
Price Target: $77.36

Globus Medical MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.89 Rating Score
Upside/Downside: 21.3% Upside
$77.36 Price Target
Short Interest: Bearish
6.63% of Float Sold Short
Dividend Strength: N/A
Sustainability: -0.93
Upright™ Environmental Score
News Sentiment: 0.27
Based on 17 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 14.76%
From $2.10 to $2.41 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.25 out of 5 stars

Medical Sector

382nd out of 1,098 stocks

Surgical & Medical Instruments Industry

40th out of 112 stocks

2.4

Analyst's Opinion

Consensus Rating
Globus Medical has received a consensus rating of Buy. The company's average rating score is 2.89, and is based on 8 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $77.36, Globus Medical has a forecasted upside of 21.3% from its current price of $63.79.
Amount of Analyst Coverage
Globus Medical has only been the subject of 3 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
6.63% of the float of Globus Medical has been sold short.
Short Interest Ratio / Days to Cover
Globus Medical has a short interest ratio ("days to cover") of 6.1.
Change versus previous month
Short interest in Globus Medical has recently increased by 5.07%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Globus Medical does not currently pay a dividend.
Dividend Growth
Globus Medical does not have a long track record of dividend growth.

4.1

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Globus Medical has received a 57.33% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Neurostimulators", "Synthetic bone grafts", "Artificial joints", and "Robotic surgery systems" products. See details.
Environmental Sustainability
The Environmental Impact score for Globus Medical is -0.93.

1.8

News and Social Media Coverage

News Sentiment
Globus Medical has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 17 news articles for Globus Medical this week, compared to 2 articles on an average week.
Search Interest
Only 2 people have searched for GMED on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
MarketBeat Follows
Only 3 people have added Globus Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Globus Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
24.41% of the stock of Globus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
67.19% of the stock of Globus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Globus Medical are expected to grow by 14.76% in the coming year, from $2.10 to $2.41 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Globus Medical is 42.81, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 136.48.
Price to Earnings Ratio vs. Sector
The P/E ratio of Globus Medical is 42.81, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 119.13.
Price to Earnings Growth Ratio
Globus Medical has a PEG Ratio of 3.01. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Globus Medical has a P/B Ratio of 3.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Globus Medical (NYSE:GMED) Stock

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Analysts Set New Price Targets

GMED has been the topic of several recent research reports. BTIG Research reduced their price target on Globus Medical to $71.00 in a research note on Tuesday. Wells Fargo & Company reduced their price target on Globus Medical from $80.00 to $70.00 in a research note on Wednesday, May 11th. Truist Financial reduced their price target on Globus Medical from $76.00 to $71.00 and set a "buy" rating on the stock in a research note on Wednesday, July 20th. Piper Sandler reduced their price target on Globus Medical from $80.00 to $75.00 and set an "overweight" rating on the stock in a research note on Friday. Finally, Canaccord Genuity Group reduced their price target on Globus Medical from $80.00 to $75.00 in a research note on Wednesday, May 11th. Two research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, Globus Medical has an average rating of "Moderate Buy" and an average price target of $77.36.

Globus Medical Stock Up 0.4 %

Shares of NYSE:GMED traded up $0.27 during trading on Tuesday, reaching $63.79. The company had a trading volume of 741,489 shares, compared to its average volume of 708,700. Globus Medical has a 12-month low of $52.60 and a 12-month high of $84.23. The stock has a market cap of $6.49 billion, a PE ratio of 42.65, a P/E/G ratio of 3.01 and a beta of 1.13. The business's 50-day moving average is $58.49 and its 200 day moving average is $65.38.

Globus Medical (NYSE:GMED - Get Rating) last released its quarterly earnings data on Tuesday, May 10th. The medical device company reported $0.42 EPS for the quarter, missing the consensus estimate of $0.46 by ($0.04). Globus Medical had a net margin of 15.91% and a return on equity of 11.81%. The business had revenue of $230.55 million for the quarter, compared to analysts' expectations of $232.88 million. During the same period last year, the business earned $0.49 earnings per share. The company's quarterly revenue was up 1.4% on a year-over-year basis. On average, analysts anticipate that Globus Medical will post 2.1 earnings per share for the current year.

Receive GMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter.

GMED Stock News Headlines

August 8, 2022 | americanbankingnews.com

Piper Sandler Lowers Globus Medical (NYSE:GMED) Price Target to $75.00

August 5, 2022 | finance.yahoo.com

Globus Medical (GMED) Q2 Earnings Beat, Gross Margin Dips

August 10, 2022 | Paradigm Press (Ad)

US Dollar Replaced By "Biden Bucks"?

A former advisor to the CIA and Pentagon now believes President Biden plans to retire the US dollar we know. And replace it with what he calls 'Biden Bucks'. It is underway.

August 5, 2022 | markets.businessinsider.com

Analyst Ratings for Globus Medical

August 5, 2022 | seekingalpha.com

Globus Medical, Inc. (GMED) CEO Daniel Scavilla on Q2 2022 Results - Earnings Call Transcript

August 5, 2022 | finance.yahoo.com

Globus Medical (GMED) Q2 2022 Earnings Call Transcript

August 4, 2022 | finance.yahoo.com

Globus Medical Reports Second Quarter 2022 Results

August 4, 2022 | finance.yahoo.com

Globus Medical (GMED) Q2 Earnings and Revenues Top Estimates

August 10, 2022 | Paradigm Press (Ad)

US Dollar Replaced By "Biden Bucks"?

A former advisor to the CIA and Pentagon now believes President Biden plans to retire the US dollar we know. And replace it with what he calls 'Biden Bucks'. It is underway.

August 4, 2022 | finance.yahoo.com

Declining Stock and Decent Financials: Is The Market Wrong About Globus Medical, Inc. (NYSE:GMED)?

August 3, 2022 | americanbankingnews.com

Globus Medical (GMED) Scheduled to Post Quarterly Earnings on Thursday

August 1, 2022 | americanbankingnews.com

Globus Medical, Inc. (NYSE:GMED) Given Consensus Rating of "Moderate Buy" by Analysts

July 27, 2022 | finance.yahoo.com

Globus Medical Announces First Surgeries Using ExcelsiusGPS® In Sydney

July 23, 2022 | americanbankingnews.com

Globus Medical (NYSE:GMED) PT Lowered to $71.00 at Truist Financial

July 18, 2022 | americanbankingnews.com

Globus Medical (NYSE:GMED) Given New $62.00 Price Target at Morgan Stanley

July 15, 2022 | markets.businessinsider.com

What 5 Analyst Ratings Have To Say About Globus Medical

July 12, 2022 | nasdaq.com

AngioDynamics (ANGO) Q4 Earnings Match Estimates

July 5, 2022 | finance.yahoo.com

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

June 27, 2022 | finance.yahoo.com

Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term

June 18, 2022 | morningstar.com

Globus Medical Inc Class A - Stock Quote GMED

June 10, 2022 | msn.com

Globus Medical's Return On Invested Capital Insights

June 9, 2022 | finance.yahoo.com

Why Is Globus Medical (GMED) Up 1.7% Since Last Earnings Report?

June 7, 2022 | finance.yahoo.com

Here's Why Investors Should Retain Globus Medical (GMED) Now

June 6, 2022 | finance.yahoo.com

The total return for Globus Medical (NYSE:GMED) investors has risen faster than earnings growth over the last five years

May 20, 2022 | nasdaq.com

First Week of July 15th Options Trading For Globus Medical (GMED)

May 18, 2022 | finance.yahoo.com

Globus Medical Announces First Surgeries Using Excelsius3D™

May 11, 2022 | markets.businessinsider.com

What 6 Analyst Ratings Have To Say About Globus Medical

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive GMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter.

GMED Company Calendar

Last Earnings: 11/04/2021
Today: 8/09/2022
Next Earnings (Estimated): 11/03/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NYSE:GMED
CUSIP: 37957720
CIK: 1237831
Web: www.globusmedical.com
Phone: (610) 930-1800
Fax: 610-930-2042
Employees: 2,400
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $77.36
High Stock Price Forecast: $100.00
Low Stock Price Forecast: $62.00
Forecasted Upside/Downside: +21.3%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.89
Research Coverage: 9 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.49
Trailing P/E Ratio: 42.81
Forward P/E Ratio: 30.38
P/E Growth: 3.01
Net Income: $149.19 million
Net Margins: 15.91%
Pretax Margin: 19.89%
Return on Equity: 11.81%
Return on Assets: 10.54%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.10
Quick Ratio: 4.28

Sales & Book Value

Annual Sales: $958.10 million
Price / Sales: 6.77
Cash Flow: $2.84 per share
Price / Cash Flow: 22.50
Book Value: $17.15 per share
Price / Book: 3.72

Miscellaneous

Outstanding Shares: 101,751,000
Free Float: 76,914,000
Market Cap: $6.49 billion
Optionable: Optionable
Beta: 1.13

Key Executives

Mr. David C. Paul (Age 55)
Co-Founder & Exec. Chairman
Comp: $23.57k
Mr. Daniel T. Scavilla (Age 57)
Pres, CEO & Director
Comp: $965.17k
Mr. Keith W. Pfeil (Age 43)
Sr. VP & CFO
Comp: $623.41k
Ms. Kelly G. Huller Esq. (Age 50)
Sr. VP, Gen. Counsel & Sec.
Comp: $543.02k
Mr. Brian J. Kearns (Age 55)
Sr. VP of Bus. Devel. & Investor Relations
Mr. A. Brett Murphy (Age 57)
Exec. VP of International Sales
Mr. Steven M. Payne (Age 51)
VP & Controller
Mr. Mike Reeder
Exec. Officer
Mr. Richard Holifield
Exec. Officer
Mr. John Dowling
Exec. Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

GMED Stock - Frequently Asked Questions

Should I buy or sell Globus Medical stock right now?: 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Globus Medical in the last year. There are currently 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" GMED shares.
View GMED analyst ratings or view top-rated stocks.
What is Globus Medical's stock price forecast for 2022?: 9 analysts have issued 12-month target prices for Globus Medical's stock. Their GMED share price forecasts range from $62.00 to $100.00. On average, they anticipate the company's share price to reach $77.36 in the next twelve months. This suggests a possible upside of 21.3% from the stock's current price.
View analysts price targets for GMED or view top-rated stocks among Wall Street analysts.
How has Globus Medical's stock performed in 2022?: Globus Medical's stock was trading at $72.20 at the beginning of the year. Since then, GMED shares have decreased by 11.6% and is now trading at $63.79.
View the best growth stocks for 2022 here.
When is Globus Medical's next earnings date?: Globus Medical is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our GMED earnings forecast.
How were Globus Medical's earnings last quarter?: Globus Medical, Inc. (NYSE:GMED) posted its quarterly earnings results on Thursday, November, 4th. The medical device company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.05. The medical device company had revenue of $229.72 million for the quarter, compared to analyst estimates of $228.28 million. Globus Medical had a net margin of 15.91% and a trailing twelve-month return on equity of 11.81%. The company's revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.49 EPS.
What guidance has Globus Medical issued on next quarter's earnings?: Globus Medical updated its FY22 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of $2.10 for the period, compared to the consensus earnings per share estimate of $2.10. The company issued revenue guidance of $1.025 billion, compared to the consensus revenue estimate of $1.02 billion.

What is David Demski's approval rating as Globus Medical's CEO?: 47 employees have rated Globus Medical Chief Executive Officer David Demski on Glassdoor.com. David Demski has an approval rating of 61% among the company's employees. This puts David Demski in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Globus Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Globus Medical investors own include NVIDIA (NVDA), Shopify (SHOP), CrowdStrike (CRWD), Okta (OKTA), Trade Desk (TTD), Block (SQ), Tesla (TSLA), Teladoc Health (TDOC), Zoom Video Communications (ZM) and Mastercard (MA).
What is Globus Medical's stock symbol?: Globus Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMED."
Who are Globus Medical's major shareholders?: Globus Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Geneva Capital Management LLC (1.33%), Van Berkom & Associates Inc. (0.87%), Paradigm Capital Management Inc. NY (0.68%), Boston Trust Walden Corp (0.63%), Pembroke Management LTD (0.59%) and Loomis Sayles & Co. L P (0.50%). Insiders that own company stock include Daniel T Scavilla, Daniel T Scavilla, David D Davidar, David M Demski, James R Tobin, James R Tobin, Keith W Pfeil, Keith W Pfeil, Kelly Huller and Robert Andrew Douglas.
View institutional ownership trends.
How do I buy shares of Globus Medical?: Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Globus Medical's stock price today?: One share of GMED stock can currently be purchased for approximately $63.79.
How much money does Globus Medical make?: Globus Medical (NYSE:GMED) has a market capitalization of $6.49 billion and generates $958.10 million in revenue each year. The medical device company earns $149.19 million in net income (profit) each year or $1.49 on an earnings per share basis.
How many employees does Globus Medical have?: Globus Medical employs 2,400 workers across the globe.
How can I contact Globus Medical?: Globus Medical's mailing address is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. The official website for the company is www.globusmedical.com. The medical device company can be reached via phone at (610) 930-1800, via email at investors@globusmedical.com, or via fax at 610-930-2042.

This page (NYSE:GMED) was last updated on 8/10/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Globus Medical - GMED Stock Forecast, Price & News

Globus Medical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Globus Medical (NYSE:GMED) Stock

Analysts Set New Price Targets

Globus Medical Stock Up 0.4 %

GMED Stock News Headlines

GMED Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

GMED Stock - Frequently Asked Questions

Should I buy or sell Globus Medical stock right now?

What is Globus Medical's stock price forecast for 2022?

How has Globus Medical's stock performed in 2022?

When is Globus Medical's next earnings date?

How were Globus Medical's earnings last quarter?

What guidance has Globus Medical issued on next quarter's earnings?

What is David Demski's approval rating as Globus Medical's CEO?

What other stocks do shareholders of Globus Medical own?

What is Globus Medical's stock symbol?

Who are Globus Medical's major shareholders?

How do I buy shares of Globus Medical?

What is Globus Medical's stock price today?

How much money does Globus Medical make?

How many employees does Globus Medical have?

How can I contact Globus Medical?

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™